Pancreatic Cancer
Pancreatic cancer is a type of cancer that begins in the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice.
Stomach and Pancreatic Cancer: ASP2138 Treatment Study
We are investigating the effects of ASP2138 alone and with other cancer treatments for adults with stomach, gastroesophageal junction, or pancreatic cancer. This study aims to see if it can improve treatment results.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Stomach Cancer
Stomach cancer, or gastric adenocarcinoma, is a type of cancer that starts in the stomach lining, causing symptoms such as stomach pain, nausea, and difficulty swallowing.
Gastroesophageal Junction Cancer
Gastroesophageal junction cancer is a type of cancer that occurs where the esophagus meets the stomach, leading to symptoms like difficulty swallowing, chest pain, and weight loss.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Paoli-Calmettes
Medical Oncology
Marseille, France
Centre Leon Berard
Medical Oncology
Meyzieu, France
Institut De Cancerologie De L Ouest
Medical Oncology
Orvault, France
Sponsor: Astellas Pharma Global Development Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.